These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 20047147)

  • 21. In vitro drug-drug interaction studies with febuxostat, a novel non-purine selective inhibitor of xanthine oxidase: plasma protein binding, identification of metabolic enzymes and cytochrome P450 inhibition.
    Mukoyoshi M; Nishimura S; Hoshide S; Umeda S; Kanou M; Taniguchi K; Muroga H
    Xenobiotica; 2008 May; 38(5):496-510. PubMed ID: 18421623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-mediated inactivation of cytochrome P450.
    Murray M
    Clin Exp Pharmacol Physiol; 1997 Jul; 24(7):465-70. PubMed ID: 9248661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use.
    Luethi D; Hoener MC; Krähenbühl S; Liechti ME; Duthaler U
    Biochem Pharmacol; 2019 Jun; 164():129-138. PubMed ID: 30981875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions.
    Prakash C; Kamel A; Cui D; Whalen RD; Miceli JJ; Tweedie D
    Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):35S-42S. PubMed ID: 10771452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidation of 3-aminobenzanthrone, a human metabolite of carcinogenic environmental pollutant 3-nitrobenzanthrone, by cytochromes P450 - similarity between human and rat enzymes.
    Mizerovska J; Dracinska H; Arlt VM; Schmeiser HH; Frei E; Stiborova M
    Neuro Endocrinol Lett; 2009; 30 Suppl 1():52-9. PubMed ID: 20027145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro evaluation of reversible and irreversible cytochrome P450 inhibition: current status on methodologies and their utility for predicting drug-drug interactions.
    Fowler S; Zhang H
    AAPS J; 2008 Jun; 10(2):410-24. PubMed ID: 18686042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on in vitro studies.
    Donato MT; Castell JV
    Clin Pharmacokinet; 2003; 42(2):153-78. PubMed ID: 12537515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorescence-Based High-Throughput Assays for Investigating Cytochrome P450 Enzyme-Mediated Drug-Drug Interactions.
    He R; Dai Z; Finel M; Zhang F; Tu D; Yang L; Ge G
    Drug Metab Dispos; 2023 Oct; 51(10):1254-1272. PubMed ID: 37349113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of cytochrome-P450 inhibition (CYP) in drug discovery: a medicinal chemistry perspective.
    Kumar S; Sharma R; Roychowdhury A
    Curr Med Chem; 2012; 19(21):3605-21. PubMed ID: 22680629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions.
    Ohyama K; Nakajima M; Suzuki M; Shimada N; Yamazaki H; Yokoi T
    Br J Clin Pharmacol; 2000 Mar; 49(3):244-53. PubMed ID: 10718780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of enzyme inhibition kinetics in drug-drug interactions.
    Chen A; Qin X; Tang Y; Liu M; Wang X
    Chem Biol Interact; 2014 Oct; 222():133-4. PubMed ID: 25451570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of metabolites to P450 inhibition-based drug-drug interactions: scholarship from the drug metabolism leadership group of the innovation and quality consortium metabolite group.
    Yu H; Balani SK; Chen W; Cui D; He L; Humphreys WG; Mao J; Lai WG; Lee AJ; Lim HK; MacLauchlin C; Prakash C; Surapaneni S; Tse S; Upthagrove A; Walsky RL; Wen B; Zeng Z
    Drug Metab Dispos; 2015 Apr; 43(4):620-30. PubMed ID: 25655830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of in vivo drug-drug interactions from in vitro data : factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4.
    Brown HS; Galetin A; Hallifax D; Houston JB
    Clin Pharmacokinet; 2006; 45(10):1035-50. PubMed ID: 16984215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytochrome P450 Structure, Function and Clinical Significance: A Review.
    Manikandan P; Nagini S
    Curr Drug Targets; 2018; 19(1):38-54. PubMed ID: 28124606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug metabolites as cytochrome p450 inhibitors: a retrospective analysis and proposed algorithm for evaluation of the pharmacokinetic interaction potential of metabolites in drug discovery and development.
    Callegari E; Kalgutkar AS; Leung L; Obach RS; Plowchalk DR; Tse S
    Drug Metab Dispos; 2013 Dec; 41(12):2047-55. PubMed ID: 23792812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition and induction of CYP enzymes in humans: an update.
    Hakkola J; Hukkanen J; Turpeinen M; Pelkonen O
    Arch Toxicol; 2020 Nov; 94(11):3671-3722. PubMed ID: 33111191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19.
    Ha-Duong NT; Dijols S; Macherey AC; Goldstein JA; Dansette PM; Mansuy D
    Biochemistry; 2001 Oct; 40(40):12112-22. PubMed ID: 11580286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vitro Assessment of Potential for CYP-Inhibition-Based Drug-Drug Interaction Between Vonoprazan and Clopidogrel.
    Nishihara M; Yamasaki H; Czerniak R; Jenkins H
    Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):217-227. PubMed ID: 30361928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes.
    Tanaka E
    J Clin Pharm Ther; 1998 Dec; 23(6):403-16. PubMed ID: 10048501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights on cytochrome p450 enzymes and inhibitors obtained through QSAR studies.
    Sridhar J; Liu J; Foroozesh M; Stevens CL
    Molecules; 2012 Aug; 17(8):9283-305. PubMed ID: 22864238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.